| RS1057518576 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1057518577 |
GRIN2B
|
Health Risk |
Pathogenic |
— |
| RS1057518578 |
ANKRD11
|
Health Risk |
Likely pathogenic |
— |
| RS1057518579 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1057518580 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1057518587 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy |
| RS1057518588 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2S, Autosomal recessive distal spinal muscular atrophy 1 |
| RS1057518593 |
TUBB3
|
Health Risk |
Likely pathogenic |
— |
| RS1057518594 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS1057518596 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1057518597 |
TGFB2
|
Health Risk |
Likely pathogenic |
— |
| RS1057518598 |
CUL4B
|
Health Risk |
Likely pathogenic |
— |
| RS1057518600 |
PCYT1A
|
Health Risk |
Likely pathogenic |
— |
| RS1057518602 |
AKT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 6, Cowden syndrome 6 |
| RS1057518603 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518604 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS1057518605 |
NAA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Ogden syndrome |
| RS1057518613 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1057518614 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1057518615 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
CACNA1A-related disorder, CACNA1A-related disorder |
| RS1057518616 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1057518618 |
RARS1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1057518619 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1057518621 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1057518623 |
EXT1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518625 |
ALG1
|
Health Risk |
Pathogenic |
— |
| RS1057518626 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS1057518627 |
DVL1
|
Health Risk |
Likely pathogenic |
— |
| RS1057518628 |
CD40LG
|
Health Risk |
Likely pathogenic |
— |
| RS1057518629 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1057518632 |
PIGO
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1057518633 |
WAS
|
Health Risk |
Pathogenic |
— |
| RS1057518635 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS1057518636 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS1057518637 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS1057518638 |
BRCA2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS1057518639 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast neoplasm, Hereditary breast ovarian cancer syndrome |
| RS1057518641 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast neoplasm, Hereditary cancer-predisposing syndrome |
| RS1057518643 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057518644 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1057518645 |
C1R
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057518646 |
C1R
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, periodontal type 1 |
| RS1057518647 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypobetalipoproteinemia |
| RS1057518648 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, ARID1B-related BAFopathy |
| RS1057518650 |
BRWD3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 93 |
| RS1057518653 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1057518654 |
COL4A1
|
Health Risk |
Likely pathogenic |
Brain small vessel disease 1 with or without ocular anomalies, Brain small vessel disease 1 with or without ocular anomalies |
| RS1057518655 |
DNM1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS1057518656 |
SOX10
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 2E, Waardenburg syndrome type 2E |
| RS1057518657 |
GLI2
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS1057518658 |
SCN2A
|
Health Risk |
Pathogenic |
Autism, Autism |
| RS1057518659 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1057518660 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, SHH-related disorder |
| RS1057518661 |
NOTCH1
|
Health Risk |
Pathogenic |
Aortic valve disease 1, Aortic valve disease 1 |
| RS1057518662 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057518663 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1057518665 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, KRIT1-related disorder |
| RS1057518666 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Stickler syndrome |
| RS1057518667 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1057518668 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS1057518669 |
SOX9
|
Health Risk |
Likely pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS1057518670 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1057518671 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1057518672 |
SOX11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism |
| RS1057518673 |
ACTG1
|
Health Risk |
Likely pathogenic |
Baraitser-winter syndrome 2, Baraitser-winter syndrome 2 |
| RS1057518674 |
GATAD2B
|
Health Risk |
Pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1057518677 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1057518678 |
GNAO1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS1057518679 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1057518680 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1057518681 |
PUF60
|
Health Risk |
Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1057518682 |
MEGF10
|
Health Risk |
Likely pathogenic |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS1057518683 |
SPRED1
|
Health Risk |
Pathogenic/Likely pathogenic |
Legius syndrome, Cardiovascular phenotype |
| RS1057518685 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS1057518686 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS1057518687 |
NLRC4
|
Health Risk |
Likely pathogenic |
Periodic fever-infantile enterocolitis-autoinflammatory syndrome, Periodic fever-infantile enterocolitis-autoinflammatory syndrome |
| RS1057518688 |
CACNB4
|
Health Risk |
Pathogenic |
Epilepsy, idiopathic generalized |
| RS1057518689 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS1057518691 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, ARID1B-related BAFopathy |
| RS1057518692 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1057518694 |
DNM1L
|
Health Risk |
Likely pathogenic |
Encephalopathy, lethal |
| RS1057518696 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS1057518697 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Spastic paraplegia |
| RS1057518698 |
GLI3
|
Health Risk |
Pathogenic |
Polydactyly, postaxial |
| RS1057518699 |
LAS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson-Turner syndrome, Global developmental delay |
| RS1057518700 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1057518701 |
SHOX
|
Health Risk |
Pathogenic |
SHOX-related short stature, SHOX-related short stature |
| RS1057518702 |
PDHA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1057518703 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS1057518704 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS1057518705 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1057518706 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS1057518707 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS1057518708 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1057518711 |
NPC1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1057518713 |
SLC12A6
|
Health Risk |
Pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS1057518714 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1057518715 |
AGPAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1057518716 |
OBSL1
|
Health Risk |
Pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS1057518718 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |